SYSTEMATIC REVIEW
Published on 16 Apr 2025
Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer’s disease
doi 10.3389/fphar.2025.1599048
- 1,466 views
- Frontiers in Pharmacology
- Integrative and Regenerative Pharmacology
- Research Topics
- Challenges and Opportunities with the Rollout of New Alzheimer’s Disease Drugs: A Focus on Non-Alzheimer's Dementia
Challenges and Opportunities with the Rollout of New Alzheimer’s Disease Drugs: A Focus on Non-Alzheimer's Dementia
2,546
Total downloads
10k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 22 Aug 2024
Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis
doi 10.3389/fphar.2024.1451032
- 4,070 views
- 2 citations
REVIEW
Published on 16 Jul 2024
Herbal medicines in Alzheimer’s disease and the involvement of gut microbiota
doi 10.3389/fphar.2024.1416502
- 2,413 views
- 1 citation
Published in
Frontiers in Pharmacology
Integrative and Regenerative Pharmacology
Neuropharmacology
Participating Journals
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: